PharmaSpace: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PharmaSpace
Largest movements
- Intangible fixed assets -€32,217
down €32,217 (-34.3%), from €94,054 to €61,837
- Cash -€29,618
down €29,618 (-42.8%), from €69,154 to €39,536
mainly Debts after one year (-€52,302) and Trade debts (-€36,363)
- Tangible fixed assets -€26,396
down €26,396 (-19.3%), from €136,750 to €110,354
of which Plant, machinery and equipment: -€27,045
- Stocks and contracts +€24,178
up €24,178 (+12.7%), from €190,171 to €214,349
- Debts after one year -€52,302
down €52,302 (-35.7%), from €146,418 to €94,116
- Trade debts -€36,363
down €36,363 (-24.9%), from €146,129 to €109,767
- Reserves +€27,304
up €27,304 (+59.1%), from €46,200 to €73,504
of which Distributable reserves: +€27,304
- Other debts -€16,000
down €16,000 (-24.2%), from €66,000 to €50,000
- Tax, wage and social debts +€10,481
up €10,481 (+57.7%), from €18,152 to €28,633
of which Taxes: +€12,938
- Gross operating margin +€31,295
up €31,295 (+10.1%), from €310,402 to €341,697
- Taxes +€5,161
up €5,161 (+66.0%), from €7,814 to €12,974
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €554,675 | €486,580 | -€68,095 | -12.3% |
| Fixed assets | 21/28 | €241,003 | €182,391 | -€58,613 | -24.3% |
| Intangible fixed assets | 21 | €94,054 | €61,837 | -€32,217 | -34.3% |
| Tangible fixed assets | 22/27 | €136,750 | €110,354 | -€26,396 | -19.3% |
| Plant, machinery and equipment | 23 | €136,636 | €109,591 | -€27,045 | -19.8% |
| Furniture and vehicles | 24 | €114 | €763 | +€649 | +570.1% |
| Financial fixed assets | 28 | €10,200 | €10,200 | = | 0.0% |
| Current assets | 29/58 | €313,672 | €304,189 | -€9,482 | -3.0% |
| Stocks and contracts in progress | 3 | €190,171 | €214,349 | +€24,178 | +12.7% |
| Stocks | 30/36 | €190,171 | €214,349 | +€24,178 | +12.7% |
| Amounts receivable within one year | 40/41 | €46,255 | €42,293 | -€3,963 | -8.6% |
| Trade receivables | 40 | €46,255 | €42,278 | -€3,977 | -8.6% |
| Other amounts receivable | 41 | - | €14 | +€14 | |
| Cash at bank and in hand | 54/58 | €69,154 | €39,536 | -€29,618 | -42.8% |
| Deferred charges and accrued income | 490/1 | €8,091 | €8,012 | -€79 | -1.0% |
| Total equity and liabilities | 10/49 | €554,675 | €486,580 | -€68,095 | -12.3% |
| Equity | 10/15 | €121,200 | €148,504 | +€27,304 | +22.5% |
| Contributions | 10/11 | €75,000 | €75,000 | = | 0.0% |
| Reserves | 13 | €46,200 | €73,504 | +€27,304 | +59.1% |
| Non-distributable reserves | 130/1 | €0 | - | = | |
| Reserves not available under the articles | 1311 | €0 | - | = | |
| Distributable reserves | 133 | €46,200 | €73,504 | +€27,304 | +59.1% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €433,475 | €338,076 | -€95,399 | -22.0% |
| Amounts payable after more than one year | 17 | €146,418 | €94,116 | -€52,302 | -35.7% |
| Financial debts | 170/4 | €146,418 | €94,116 | -€52,302 | -35.7% |
| Amounts payable within one year | 42/48 | €282,584 | €240,702 | -€41,882 | -14.8% |
| Current portion of amounts payable after more than one year | 42 | €52,302 | €52,302 | = | 0.0% |
| Trade debts | 44 | €146,129 | €109,767 | -€36,363 | -24.9% |
| Suppliers | 440/4 | €146,129 | €109,767 | -€36,363 | -24.9% |
| Taxes, remuneration and social security | 45 | €18,152 | €28,633 | +€10,481 | +57.7% |
| Taxes | 450/3 | €2,818 | €15,756 | +€12,938 | +459.2% |
| Remuneration and social security | 454/9 | €15,335 | €12,877 | -€2,457 | -16.0% |
| Other amounts payable | 47/48 | €66,000 | €50,000 | -€16,000 | -24.2% |
| Accrued charges and deferred income | 492/3 | €4,473 | €3,258 | -€1,215 | -27.2% |
| Remuneration, social security and pensions | 62 | €203,235 | €206,032 | +€2,796 | +1.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €59,924 | €59,408 | -€516 | -0.9% |
| Other operating charges | 640/8 | €665 | €676 | +€10 | +1.5% |
| Gross operating margin | 9900 | €310,402 | €341,697 | +€31,295 | +10.1% |
| Operating profit (loss) | 9901 | €46,577 | €75,582 | +€29,005 | +62.3% |
| Financial income | 75/76B | €1,872 | €1,932 | +€59 | +3.2% |
| Recurring financial income | 75 | €1,872 | €1,932 | +€59 | +3.2% |
| Financial charges | 65/66B | €14,400 | €12,236 | -€2,164 | -15.0% |
| Recurring financial charges | 65 | €14,400 | €12,236 | -€2,164 | -15.0% |
| Profit (loss) for the period before taxes | 9903 | €34,050 | €65,278 | +€31,228 | +91.7% |
| Income taxes | 67/77 | €7,814 | €12,974 | +€5,161 | +66.0% |
| Profit (loss) for the period | 9904 | €26,236 | €52,304 | +€26,068 | +99.4% |
| Profit (loss) for the period to be appropriated | 9905 | €26,236 | €52,304 | +€26,068 | +99.4% |
Source: filed annual accounts (NBB), fiscal years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.